The US Food and Drug Administration (USFDA) conducted an inspection of the company’s Digwal (Telangana ) based plant from February 9, 2026, to February 13, 2026
Source link
#USFDA #issues #Form #observations #Piramal #Pharmas #Telangana #unit
Trending
- Video: Venezuela Releases Political Prisoners, With Conditions
- U.K. stocks higher at close of trade; Investing.com United Kingdom 100 up 0.59%
- He set aside political differences: Dhar on Dr Syngkon
- Gambonanza reshapes chess into a roguelike strategy experiment during Steam Next Fest
- ‘Selling Sunset’s Sandra Vergara Discusses Christine Quinn’s Possible Return
- Donald Trump could seek third term, Japan gas cloud, Iran strikes: ‘Prophet of Doom’ issues chilling 2026 visions | – The Times of India
- Johnson & Johnson’s $1B Pennsylvania Plant Will Support Over 4,000 Construction Jobs
- The economy caught a chill from Winter Storm Fern and tariffs are a lingering problem, S&P finds
USFDA issues Form 483 with 4 observations to Piramal Pharma’s Telangana unit
